Bladder seen under White Light

Bladder seen under Blue Light

Confidence for Bladder Cancer Patients Making cancer visible
This video shows a bladder cancer surgery procedure (TURBT) performed with Blue Light as adjunct to White Light Cystoscopy. With courtesy of Maximillian Burger, Germany
Latest News See more news
  • 23.05.2018
    Results for the first quarter of 2018

    Oslo, Norway, 23 May 2018: Photocure ASA (OSE:PHO), today reported a revenue growth of 36% in local currency for the important U.S. market in the first quarter of 2018, contributing to Hexvix/Cysview revenues of NOK 40.7 million (Q1 2017: NOK 36.5) and a recurring EBITDA of NOK -4.3 million (NOK -4.0 million). With the reimbursement of Blue Light Cystoscopy with Cysview, FDA approval of label expansion for Cysview and the launch of Cysview in combination with flexible cystoscopes in the surveillance of bladder cancer patients, the company expects a continued solid growth towards the 2020 ambitions.

  • 16.05.2018
    Presentation of the first quarter 2018 results

    Photocure will present its first quarter 2018 report on Wednesday 23 May 2018 at Hotel Continental, Oslo, Norway.

  • 16.05.2018
    Photocure Announces Blue Light Cystoscopy with Cysview® now available for surveillance of bladder cancer

    Oslo, Norway, Photocure ASA (OSE: PHO), May 16, 2018, announced today the launch of Blue Light Cystoscopy (BLCâ„¢) with Cysview for a new indication of surveillance cystoscopy of bladder cancer.

Photocure, The Bladder Cancer Company, delivers transformative solutions to improve the lives of bladder cancer patients